Author Question: A patient who is taking delavirdine (Rescriptor) as part of combination therapy for human ... (Read 59 times)

plus1 · **on:** Jul 23, 2018

A patient who is taking delavirdine (Rescriptor) as part of combination therapy for human im-munodeficiency virus (HIV) complains of rash, fever, and headache. Which of the following in-terpretations is accurate regarding this patient's symptoms?

a. This patient's symptoms are most compatible with a frequent adverse drug effect.
b. This patient's symptoms are most compatible with lack of adherence to dosing schedule.
c. This patient's symptoms are most compatible with a hypersensitivity reaction to the drug.
d. This patient's symptoms are most compatible with worsening of the HIV infec-tion.

Question 2

The patient is being prescribed an antifungal medication after being diagnosed with oral thrush. Which drug would be an inappropriate selection for this patient?

a. Amphotericin B
b. Ketoconazole
c. Itraconazole
d. Fluconazole

macagnavarro · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Frequent adverse effects associated with delavirdine are rash, fever, nausea, headache, and ab-normal liver function tests.

Answer to Question 2

ANS: A
Amphotericin B should not be used to treat noninvasive forms of fungal disease such as oral thrush, vaginal candidiasis, and esophageal candidiasis in patients with normal neutrophil counts.